4//SEC Filing
King-Jones Heidy 4
Accession 0000950170-23-046396
CIK 0001636282other
Filed
Sep 4, 8:00 PM ET
Accepted
Sep 5, 4:15 PM ET
Size
5.5 KB
Accession
0000950170-23-046396
Insider Transaction Report
Form 4
King-Jones Heidy
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2023-09-01+13,495,255→ 13,495,255 totalExercise: $0.58Exp: 2033-09-01→ Common Stock (13,495,255 underlying)
Footnotes (1)
- [F1]This option represents the right to purchase 13,495,255 shares of the Issuer's common stock, one quarter of which will vest and become exercisable on September 1, 2024, with the remaining three quarters vesting in monthly installments over the following three years, subject to the Reporting Person's continued employment with the Issuer.
Documents
Issuer
Aeglea BioTherapeutics, Inc.
CIK 0001636282
Entity typeother
Related Parties
1- filerCIK 0001794898
Filing Metadata
- Form type
- 4
- Filed
- Sep 4, 8:00 PM ET
- Accepted
- Sep 5, 4:15 PM ET
- Size
- 5.5 KB